Put your weight loss journey in the hands of a medical expert Your best chance to effectively and rapidly achieve your weight loss goals is to be under the care of a doctor who has completed training and Board Certification in Obesity Medicine
Foundayo (Orforglipron) Foundayo, approved in April 2026, provides the latest advancements in GLP-1 weight management
IV most direct, and where the rare-but-serious allergic and dosing-related risks live
Incorrect dosage, unhealthy lifestyle, consuming a high-calorie diet, dehydration, lack of sleep, stress, comorbid conditions, and certain medications can affect how semaglutide works to suppress appetite
McBride encourages providers who feel confident managing obesity in primary care to be strategic and proactive in both diagnosing and escalating care